Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Talevi

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Expert Opinion on Drug Discovery|May 11, 2019
Quantitative structure-activity relationship models for compounds with anticonvulsant activityCarolina L Bellera, Alan Talevi
Current Topics in Medicinal Chemistry|October 5, 2016
Hybrid Compounds as Anti-infective AgentsMaría Laura Sbaraglini, Alan Talevi
Current Medicinal Chemistry|September 28, 2018
The Thiol-polyamine Metabolism of Trypanosoma cruzi: Molecular Targets and Drug Repurposing StrategiesAlan Talevi, Carolina Carrillo, Marcelo Comini
Methods in Molecular Biology (Clifton, N.J.)|November 3, 2025
Computer-Aided Discovery of Drugs Against Chagas DiseaseCarolina L Bellera, Lucas N Alberca, Alan Talevi
Current Topics in Medicinal Chemistry|May 10, 2018
Modern Approaches for the Discovery of Anti-Infectious Drugs for the Treatment of Neglected DiseasesCarolina L Bellera, Maria L Sbaraglini, Alan Talevi
Recent Patents on Anti-Cancer Drug Discovery|December 12, 2012
Applications of nanosystems to anticancer drug therapy (Part I. Nanogels, nanospheres, nanocapsules)Alan Talevi, Melisa E Gantner, María E Ruiz
Expert Opinion on Drug Discovery|August 31, 2025
Tackling the issue of confined chemical space with AI-based de novo drug design and molecular optimizationAlan Talevi, Lucas N Alberca, Carolina L Bellera
Recent Patents on Anti-Cancer Drug Discovery|April 13, 2013
Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems)María E Ruiz, Melisa E Gantner, Alan Talevi
Bioorganic & Medicinal Chemistry Letters|May 15, 2012
Anticonvulsant activity of artificial sweeteners: a structural link between sweet-taste receptor T1R3 and brain glutamate receptorsAlan Talevi, Andrea V Enrique, Luis E Bruno-Blanch
Molecular Diversity|October 13, 2006
Application of linear discriminant analysis in the virtual screening of antichagasic drugs through trypanothione reductase inhibitionJulián J Prieto, Alan Talevi, Luis E Bruno-Blanch
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Expert Opinion on Drug Discovery|May 11, 2019
Quantitative structure-activity relationship models for compounds with anticonvulsant activityCarolina L Bellera, Alan Talevi
Current Topics in Medicinal Chemistry|October 5, 2016
Hybrid Compounds as Anti-infective AgentsMaría Laura Sbaraglini, Alan Talevi
Current Medicinal Chemistry|September 28, 2018
The Thiol-polyamine Metabolism of Trypanosoma cruzi: Molecular Targets and Drug Repurposing StrategiesAlan Talevi, Carolina Carrillo, Marcelo Comini
Methods in Molecular Biology (Clifton, N.J.)|November 3, 2025
Computer-Aided Discovery of Drugs Against Chagas DiseaseCarolina L Bellera, Lucas N Alberca, Alan Talevi
Current Topics in Medicinal Chemistry|May 10, 2018
Modern Approaches for the Discovery of Anti-Infectious Drugs for the Treatment of Neglected DiseasesCarolina L Bellera, Maria L Sbaraglini, Alan Talevi
Recent Patents on Anti-Cancer Drug Discovery|December 12, 2012
Applications of nanosystems to anticancer drug therapy (Part I. Nanogels, nanospheres, nanocapsules)Alan Talevi, Melisa E Gantner, María E Ruiz
Expert Opinion on Drug Discovery|August 31, 2025
Tackling the issue of confined chemical space with AI-based de novo drug design and molecular optimizationAlan Talevi, Lucas N Alberca, Carolina L Bellera
Recent Patents on Anti-Cancer Drug Discovery|April 13, 2013
Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems)María E Ruiz, Melisa E Gantner, Alan Talevi
Bioorganic & Medicinal Chemistry Letters|May 15, 2012
Anticonvulsant activity of artificial sweeteners: a structural link between sweet-taste receptor T1R3 and brain glutamate receptorsAlan Talevi, Andrea V Enrique, Luis E Bruno-Blanch
Molecular Diversity|October 13, 2006
Application of linear discriminant analysis in the virtual screening of antichagasic drugs through trypanothione reductase inhibitionJulián J Prieto, Alan Talevi, Luis E Bruno-Blanch
Pageof 9